Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
FHTX
#3801
Foghorn Therapeutics Inc. - Common Stock
1.9
0
USD
-0.03%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.56%
Monthly Change
-56.92%
6 month change
-59.66%
Year Change
-53.43%
Previous Close
1.9
5
Open
1.9
1
Low
1.8
4
High
1.9
3
Markets
US Stock Market
Healthcare
Biotechnology
FHTX
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
36.82 M
41.42 M
41.8 M
42.57 M
55.61 M
58.7 M
59.39 M
Valuation ratios
Enterprise value
673.13 M
846.18 M
219.51 M
194.21 M
207.04 M
236.11 M
48.32 M
Price to earnings ratio
—
-8.38
-2.48
-2.76
-2.99
-4.58
-1.98
Price to sales ratio
—
644.51
14.06
7.93
11.46
11
3.56
Price to cash flow ratio
—
-16.92
1.4
-2.29
-2.58
-3.95
-1.54
Price to book ratio
—
8.78
2 413.79
-3.51
-5.69
-3.13
-0.36
Enterprise value to EBITDA ratio
-10.02
-8.68
-1.93
-1.86
-2.08
-2.84
-0.68
Profitability ratios
Return on assets %
-0.27
-0.19
-0.27
-0.34
-0.31
-0.37
-0.04
Return on equity %
-0.47
-1.05
-972.16
1.28
1.9
0.68
0.09
Return on invested capital %
-182.8
-188.74
-159.43
-156.61
-202.12
-340.1
—
Gross margin %
100
100
100
100
100
100
100
Operating margin %
-15.94 K
-7 637.15
-609.2
-315.93
-454.31
-279.49
-54.78
EBITDA margin %
-15.63 K
-7 392.49
-591.93
-305.83
-440.51
-268.71
-53.54
Net margin %
-16 K
-7 681.58
-566.27
-288.17
-383.24
-240.33
-44.74
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
10.12
9.44
6.37
4.11
3.73
2.73
3.36
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0.04
0.1
0.08
0.16
0.08
Solvency ratios
Debt to assets ratio
0.08
0
—
—
—
—
—
Debt to equity ratio
0.13
0
—
—
—
—
—
Long term debt to total assets ratio
0.08
—
—
—
—
—
—
Long term debt to total equity ratio
0.14
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-1.35
4.66
-2.81
-1.83
-1.37
-1.27
EBIT per share
—
-2.71
-2.82
-2.57
-1.87
-1.37
-1.11
EBITDA per share
—
-2.62
-2.74
-2.49
-1.81
-1.32
-1.08
Total debt per share
—
0
—
—
—
—
—
Cash per share
—
2.72
1.26
1.91
1.01
1.28
0.96
Net current asset value per share
—
12.36
8.45
5.72
4.55
2.59
2.41
Tangible book value per share
—
2.61
0
-1.84
-0.83
-1.72
-1.15
Working capital per share
—
11.05
7.12
4.33
3.33
1.64
1.69
Book value per share
—
2.61
0
-1.84
-0.83
-1.72
-1.15
News
12 Health Care Stocks Moving In Friday's Intraday Session
Wedbush Downgrades Foghorn Therapeutics to Neutral, Lowers Price Target to $2
TD Cowen Downgrades Foghorn Therapeutics to Hold
Guggenheim Maintains Buy on Foghorn Therapeutics, Lowers Price Target to $5
Abbott To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Friday
This AST SpaceMobile Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
HC Wainwright & Co. Maintains Buy on Foghorn Therapeutics, Lowers Price Target to $5
BTIG Downgrades Foghorn Therapeutics to Neutral
Nasdaq Gains 100 Points; ISM manufacturing PMI Slips In September
12 Health Care Stocks Moving In Thursday's Intraday Session
Foghorn Therapeutics Pivots Pipeline after Ending Eli Lilly Deal
Eli Lilly (LLY) Ends Cancer Development Deal with Foghorn Therapeutics - TipRanks.com